Mizuho Securities Reinstates PRA Health Sciences (PRAH) at Neutral
Get Alerts PRAH Hot Sheet
Price: $165.21 --0%
Rating Summary:
6 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Rating Summary:
6 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Join SI Premium – FREE
Mizuho Securities reinstates coverage on PRA Health Sciences (NASDAQ: PRAH) with a Neutral rating and a price target of $169.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $165.21 yesterday.
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
- Morgan Stanley Starts eMemory Technology Inc (3529:TT) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share